Nameplate
 |
 |
 |
|
Choose your language
 |
||
Registration
Online Registration is Open!
CSS
Document Title
Sponsors
Confirmed Sponsors
Updated: October 08, 2009
| Silver Sponsor | |
 |
For over 50 years, Bio-Rad Laboratories has provided instrumentation and reagents supporting life science research. In 2006 Bio-Rad launched the ProteOn™ XPR36 protein interaction array system, which offers a novel 6 x 6 criss-cross fluidics design and unique referencing options to measure 36 simultaneous kinetic interactions in real time. With the ProteOn XPR36 system you can continue to rely on Bio-Rad for tools, technologies, and expertise that enable genomic and proteomic analysis. |
| Technology Workshop Sponsors | |
 |
Antitope Ltd. is a privately held Cambridge UK-based biotechnology company specializing in immunogenicity testing and the engineering of therapeutic antibodies/proteins with reduced immunogenicity. Antitope's pioneering technologies include EpiScreen™ for the selection of non-immunogenic therapeutic proteins, Composite Human Antibodies™ and Composite Proteins™ for the generation of novel non-immunogenic fully humanized antibodies and protein therapeutics, respectively. Antitope continues to validate these technologies through multiple commercial relationships with leading biotechnology and pharmaceutical companies as well as through the company's own commercial pipeline. |
 |
BioWa is a subsidiary of Kyowa Hakko Kirin Co., Ltd., and exclusive licensor of AccretaMab™. AccretaMab™ consists of POTELLIGENT® and COMPLEGENT™ Technologies, creating a superior antibody molecule with enhanced ADCC and CDC activities. BioWa is committed to providing breakthrough treatments for cancer and other life-threatening diseases through these technologies. www.biowa.com |
 |
Chiome is a Tokyo based rapidly growing biotech company. It has developed a unique and innovative technology, the ADLib® system, based on chicken DT40 cells. This technology features unmatched speed, diversity of libraries, and the efficiency to generate antibodies that can not be obtained by conventional methods. |
 |
Integral Molecular is a platform-based company that provides products and services focusing on integral membrane proteins. Integral's Lipoparticle technology enables the cell-free manipulation of highly concentrated sources of membrane proteins, such as G protein-coupled receptors (GPCRs) and ion channels, for applications such as antibody development, biosensor kinetics, and high-throughput screening. Integral's Shotgun Mutagenesis mapping technology enables a residue-by-residue structure-function analysis of complex proteins, including GPCR interactions with antibodies, drugs, and natural ligands. |
 |
For over 25 years Lonza has been helping emerging and leading biotech and pharmaceutical companies increase product quality, improve production processes, navigate the regulatory process, lower cost of goods, get to market faster, and focus on core competencies. For flexible, high-quality contract manufacturing and development services and products, we can help. |
 |
Meso Scale Discovery (MSD®) develops and markets solutions for singleplex and multiplex biological assays, including assays for toxicology biomarkers, metabolic biomarkers, cytokines, and phosphoproteins. MSD's platform is based on MULTI-ARRAY® technology, a proprietary combination of patterned arrays and electrochemiluminescence detection, enabling large numbers of measurements with exceptional sensitivity, wide dynamic range, and convenience. |
 |
MorphoSys is an independent biotechnology company that develops novel antibodies for therapeutic, diagnostic and research applications. The Company's HuCAL technology is one of the most powerful methods available for generating fully human antibodies. By successfully applying its technologies, MorphoSys has become a leader in the field of therapeutic antibodies. |
 |
Open Monoclonal Technology, Inc. ("OMT") is a private, California-based biotechnology company, developing a new, fully human monoclonal antibody (mAb) platform based on transgenic rats. This new technology is the result of breakthroughs in the understanding of B-cell development and a novel approach to the inactivation of endogenous antibody expression. OMT's antibody platform has broad freedom to operate and uses technology protected by a new patent application. For more information, please visit www.omtinc.net. |
| Totebag Sponsor | |
 |
UCB is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialization of innovative products to treat severe immunology disorders and diseases in the central nervous system. UCB's Celltech Antibody Center of Excellence, located in the UK, specializes in the development of antibody-based drugs. |
| Badge & Lanyard Sponsor | |
 |
|
footer
Copyright IBC Life Sciences, a part of Informa Life Sciences GroupGlobal Information, Inc. - International Marketing Partner of Copyright IBC Life Sciences